Related Experiment Video
Updated: Aug 15, 2025

12:03
Phenotypic Analysis and Isolation of Murine Hematopoietic Stem Cells and Lineage-committed Progenitors
Published on: July 8, 2012
18.8K
Clonal hematopoiesis and inflammation - the perpetual cycle
Serine Avagyan1, Leonard I Zon2
1Dana-Farber/Boston Children's Hospital Cancer and Blood Disorders Center, Boston, MA, USA.
Trends in Cell Biology
|January 2, 2023
Summary
Clonal hematopoiesis (CH) involves blood stem cell expansion and increases risks for cancers and cardiovascular disease. This review explores inflammation's role in CH development, maintenance, and its impact on health.
Area of Science:
- Hematology
- Immunology
- Genetics
Background:
- Clonal hematopoiesis (CH) arises from acquired genetic alterations in blood stem cells, leading to their expansion.
- CH is linked to increased risks of hematologic malignancies and non-hematologic conditions like cardiovascular disease and mortality.
- Inflammation is increasingly recognized as a key factor in CH pathogenesis and its associated health risks.
Purpose of the Study:
- To review the evidence linking inflammation to the establishment and maintenance of CH.
- To explore the cellular and molecular mechanisms through which inflammation influences CH.
- To discuss the role of immune dysregulation in early-onset CH within germline predisposition conditions.
Main Methods:
- Literature review focusing on CH, inflammation, and cardiovascular disease.
- Analysis of preclinical studies elucidating cellular mechanisms of CH.
- Examination of research on germline predisposition and immune dysregulation in CH.
Main Results:
- CH is associated with specific pro-inflammatory signals.
- Preclinical studies demonstrate cellular mechanisms linking inflammation and CH.
- Immune dysregulation may play a role in early-onset CH in certain genetic conditions.
Conclusions:
- Inflammation plays a significant, reciprocal role in the development and progression of CH.
- Understanding the interplay between CH and inflammation is crucial for managing associated health risks.
- Further research into immune dysregulation in CH may reveal new therapeutic targets.
Related Concept Videos
Regulation of Hematopoietic Stem Cells
3.3K
All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
3.3K
Hematopoiesis
5.5K
The process of blood cell formation is called hematopoiesis. Hematopoiesis starts early during development, on the seventh day of embryogenesis. This phase of hematopoiesis is called the primitive wave, wherein the extraembryonic yolk sac allows the production of erythroid cells and endothelial cells from a common precursor called hemangioblast. The erythroid cells provide oxygen to support the growth of the rapidly dividing embryo. Hemangioblasts later develop into hematopoietic stem cells or...
5.5K
Overview of Hematopoiesis
4.4K
Hematopoiesis, or blood cell production, is a vital biological process that begins early in embryonic development and continues throughout life. This process generates the various types of cells found in blood, including red blood cells, white blood cells, and platelets from hematopoietic stem cells (HSCs).
Developmental Phases of Hematopoiesis
Initially, HSCs are formed in the embryonic yolk sac, a critical site for early blood cell production. These stem cells subsequently migrate to other...
Developmental Phases of Hematopoiesis
Initially, HSCs are formed in the embryonic yolk sac, a critical site for early blood cell production. These stem cells subsequently migrate to other...
4.4K
Multipotency of Hematopoietic Stem Cells
3.2K
The hematopoietic stem cells or HSCs are multipotent, meaning they can differentiate and give rise to all blood and immune cells. HSCs are maintained in the quiescent stage until an external stimulus initiates their differentiation. The multipotent HSCs exist as two heterogeneous populations, long-term repopulating cells (LTRC) and short-term repopulating cells (STRC). The two HSC populations have different surface markers or receptors and are classified based on quiescence and long-term...
3.2K
Lineage Commitment
3.0K
Commitment is the process whereby stem cells:
3.0K
Production of Formed Elements
1.5K
Hemangioblasts are multipotent stem cells originating from the mesoderm. They give rise to hematopoietic stem cells (HSCs), which undergo hematopoiesis to produce all the formed elements of blood. This process is regulated by a complex network of hematopoietic growth factors, including transcription factors, growth factors, and cytokines. These factors stimulate the HSCs to divide and differentiate, though some HSCs remain undifferentiated to maintain a self-renewing pool.
Most HSCs commit to...
Most HSCs commit to...
1.5K

